Benjamin F. Edwards & Company’s Xeris Biopharma Holdings XERS Stock Holding History

Benjamin F. Edwards & Company’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$7K	Hold	3,000	–	–	﹤0.01%	1814
2024 Q1	$7K	Hold	3,000	–	–	﹤0.01%	1800
2023 Q4	$7K	Hold	3,000	–	–	﹤0.01%	1787
2023 Q3	$6K	Hold	3,000	–	–	﹤0.01%	1535
2023 Q2	$8K	Hold	3,000	–	–	﹤0.01%	1465
2023 Q1	$5K	Hold	3,000	–	–	﹤0.01%	1562
2022 Q4	$4K	Hold	3,000	–	–	﹤0.01%	1639
2022 Q3	$5K	Hold	3,000	–	–	﹤0.01%	1573
2022 Q2	$5K	Hold	3,000	–	–	﹤0.01%	1558
2022 Q1	$8K	Hold	3,000	–	–	﹤0.01%	1436
2021 Q4	$9K	Hold	3,000	–	–	﹤0.01%	1417
2021 Q3	$7K	Hold	3,000	–	–	﹤0.01%	1469
2021 Q2	$12K	Buy	+3,000	New	+$11.4K	﹤0.01%	1352

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

Benjamin F. Edwards & Company's XERS Position: Q2 2024 in Review

Benjamin F. Edwards & Company held its Xeris Biopharma Holdings (XERS) position steady in Q2 2024 at 3,000 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Benjamin F. Edwards & Company first reported a position in XERS in Q2 2021 and has held it in 13 quarters since. The position peaked at $12K in Q2 2021. 135 funds tracked by Wall St. Rank hold XERS as of Q2 2024.

Benjamin F. Edwards & Company held 3,000 shares of Xeris Biopharma Holdings worth $7K as of Q2 2024.
Benjamin F. Edwards & Company left its Xeris Biopharma Holdings share count unchanged in Q2 2024.
Xeris Biopharma Holdings made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1814 holding.
Benjamin F. Edwards & Company first reported a position in Xeris Biopharma Holdings in Q2 2021 and has held it in 13 quarters since.
Benjamin F. Edwards & Company's Xeris Biopharma Holdings position peaked at $12K in Q2 2021.
135 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.